<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:chebi fb="6" ids="14321,29987">Glutamate</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> are protective in animal models of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Lamotrigine (3,5-diamino-6-[2,3-dichlorophenyl]-1,2,4-<z:chebi fb="0" ids="38056">triazine</z:chebi>) is an <z:chebi fb="0" ids="35623">anticonvulsant</z:chebi> drug that blocks voltage-gated <z:chebi fb="199" ids="26708">sodium</z:chebi> channels and inhibits the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced release of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>We describe the cerebroprotective effect of lamotrigine (as the isethionate salt) after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Neurological deficit and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (visualized by the lack of reduction of 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi>) 24 hours after permanent left middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> were studied in Fischer rats (n = 8 per group per dose) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Lamotrigine at 20 mg/kg i.v. over 10 minutes administered immediately after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> reduced total <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 31% and cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 52% </plain></SENT>
<SENT sid="5" pm="."><plain>Lamotrigine at 8 mg/kg i.v. over 10 minutes reduced cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 38% </plain></SENT>
<SENT sid="6" pm="."><plain>Lamotrigine at 50 mg/kg i.v. for 10 minutes was not cerebroprotective and induced a decrease of 29 +/- 15 mm Hg in mean arterial blood pressure (P &lt; .05, n = 8) </plain></SENT>
<SENT sid="7" pm="."><plain>The optimum dose of lamotrigine (20 mg/kg i.v. over 10 minutes) when administered with a 1-hour delay after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> reduced cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 41% </plain></SENT>
<SENT sid="8" pm="."><plain>Lamotrigine (20 mg/kg i.v. over 10 minutes) with a 2-hour delay after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was ineffective </plain></SENT>
<SENT sid="9" pm="."><plain>Neurological deficits after 24 hours were improved after immediate treatment with lamotrigine at 20 mg/kg i.v. over 10 minutes </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The cerebroprotective effect of lamotrigine in rats is limited to a narrow dose range between 8 and 20 mg/kg </plain></SENT>
<SENT sid="11" pm="."><plain>Lamotrigine or analogous compounds may be useful when given shortly after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>